DuPont (DD) Enters Crop Production Development Collaboration with BioLeap
Tweet
Share
E-mailGet Alerts DD Hot Sheet
Join SI Premium – FREE
DuPont Crop Protection (NYSE: DD) and BioLeap, Inc. (BioLeap) have entered into a research collaboration that will use novel molecular design technology developed at BioLeap to discover proprietary compounds for crop protection.
Under the agreement, BioLeap will use their proprietary technology in computational fragment-based design to identify compounds aimed at biological targets of interest to DuPont. A team of technical experts from both DuPont and BioLeap will then select compounds for synthesis and in vitro and in vivo evaluation by DuPont. Terms of the agreement including discovery milestones were not disclosed.
Under the agreement, BioLeap will use their proprietary technology in computational fragment-based design to identify compounds aimed at biological targets of interest to DuPont. A team of technical experts from both DuPont and BioLeap will then select compounds for synthesis and in vitro and in vivo evaluation by DuPont. Terms of the agreement including discovery milestones were not disclosed.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rapid Line sees stock surge with no known corporate cause
- Constellation Brands pledges $100M to U.S. farmers over five years
- Saba Capital renames closed-end funds ETF, ticker unchanged
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
